Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design

Cannon, 2004, Intensive versus moderate lipid lowering with statins after acute coronary syndromes, N Engl J Med, 350, 1495, 10.1056/NEJMoa040583 Ferrieres, 2005, Effect of early initiation of statins on survival in patients with acute myocardial infarction (the USIC 2000 registry), Am J Cardiol, 95, 486, 10.1016/j.amjcard.2004.10.016 Grundy, 2004, Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines, Circulation, 110, 227, 10.1161/01.CIR.0000133317.49796.0E Schwartz, 2001, Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial, JAMA, 285, 1711, 10.1001/jama.285.13.1711 Stenestrand, 2001, Early statin treatment following acute myocardial infarction and 1-year survival, JAMA, 285, 430, 10.1001/jama.285.4.430 Wright, 2002, Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit, Mayo Clin Proc, 77, 1085, 10.4065/77.10.1085 Heeschen, 2000, Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial, J Am Coll Cardiol, 35, 1535, 10.1016/S0735-1097(00)00581-7 Lindahl, 2000, Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease, N Engl J Med, 343, 1139, 10.1056/NEJM200010193431602 Morrow, 1998, C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction, J Am Coll Cardiol, 31, 1460, 10.1016/S0735-1097(98)00136-3 Mueller, 2002, Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients, Circulation, 105, 1412, 10.1161/01.CIR.0000012625.02748.62 Ridker, 2003, Clinical application of C-reactive protein for cardiovascular disease detection and prevention, Circulation, 107, 363, 10.1161/01.CIR.0000053730.47739.3C Toss, 1997, Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease, Circulation, 96, 4204, 10.1161/01.CIR.96.12.4204 Kinlay, 2003, High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study, Circulation, 108, 1560, 10.1161/01.CIR.0000091404.09558.AF Macin, 2005, Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study, Am Heart J, 149, 451, 10.1016/j.ahj.2004.07.041 Rosenson, 1993, Myocardial injury: the acute phase response and lipoprotein metabolism, J Am Coll Cardiol, 22, 933, 10.1016/0735-1097(93)90213-K Walldius, 2001, High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study, Lancet, 358, 2026, 10.1016/S0140-6736(01)07098-2 Pfohl, 1999, Upregulation of cholesterol synthesis after acute myocardial infarction – is cholesterol a positive acute phase reactant?, Atherosclerosis, 142, 389, 10.1016/S0021-9150(98)00242-1 Faulkner, 2001, Potential influence of timing of low-density lipoprotein cholesterol evaluation in patients with acute coronary syndrome, Pharmacotherapy, 21, 1055, 10.1592/phco.21.13.1055.34614 ICH. Harmonised Tripartite Guideline. Guideline for good clinical practice. 10 June 1996 ed. 53 p. http://www.ich.org/LOB/media/MEDIA482.pdf Silber, 2005, Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology, Eur Heart J, 26, 804, 10.1093/eurheartj/ehi138 Braunwald, 2002, Circulation, 106, 1893, 10.1161/01.CIR.0000030314.11999.6A Cannon, 2001, Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban, N Engl J Med, 344, 1879, 10.1056/NEJM200106213442501 De Backer, 2003, Eur J Cardiovasc Prev Rehabil, 10, S1 Jones, 2004, Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial, Clin Ther, 26, 1388, 10.1016/j.clinthera.2004.09.006 Knopp, 1999, Drug treatment of lipid disorders, N Engl J Med, 341, 498, 10.1056/NEJM199908123410707 Morrow, 2006, Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor trial, Circulation, 114, 281, 10.1161/CIRCULATIONAHA.106.628909 Arntz, 2000, Beneficial effects of pravastatin (+/− colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] study), Am J Cardiol, 86, 1293, 10.1016/S0002-9149(00)01230-3 Colivicchi, 2002, Effects of atorvastatin 80mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction, Am J Cardiol, 90, 872, 10.1016/S0002-9149(02)02711-X de Lemos, 2004, Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial, JAMA, 292, 1307, 10.1001/jama.292.11.1307 Den Hartog, 2001, Pravastatin in acute ischaemic syndromes: results of a randomised placebo-controlled trial, Int J Clin Pract, 55, 300, 10.1111/j.1742-1241.2001.tb11043.x Dupuis, 2005, Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial), Am J Cardiol, 96, 1207, 10.1016/j.amjcard.2005.06.057 Hulten, 2006, The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials, Arch Intern Med, 166, 1814, 10.1001/archinte.166.17.1814 Kayikcioglu, 2002, Early use of pravastatin in patients with acute myocardial infarction undergoing coronary angioplasty, Acta Cardiol, 57, 295, 10.2143/AC.57.4.2005430 Kesteloot, 1997, Time course of serum lipids and apolipoproteins after acute myocardial infarction: modification by pravastatin, Acta Cardiol, 52, 107 Liem, 2002, Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial, Eur Heart J, 23, 1931, 10.1053/euhj.2002.3291 Okazaki, 2004, Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study, Circulation, 110, 1061, 10.1161/01.CIR.0000140261.58966.A4 Serruys, 2002, Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial, JAMA, 287, 3215, 10.1001/jama.287.24.3215 Thompson, 2004, Effect of pravastatin compared with placebo initiated within 24h of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial, Am Heart J, 148, e2, 10.1016/j.ahj.2003.10.052 Patti, 2007, Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial, J Am Coll Cardiol, 49, 1272, 10.1016/j.jacc.2007.02.025